Pharmacovigilance vs regulatory affairs: which career path fits you?

Pharmacovigilance and regulatory affairs are both excellent entry points into pharma, but they reward different strengths. PV is closer to patient safety information and case-based thinking. Regulatory affairs is closer to submissions, labeling, authority expectations, and lifecycle planning.

Neither path is better. The right path depends on the type of work you enjoy and the kind of professional identity you want to build.

You may prefer pharmacovigilance if you like

• Case intake, triage, seriousness, expectedness, causality, MedDRA, and ICSR flow.
• Safety narratives, quality checks, reporting timelines, and inspection-ready documentation.
• Medical language, adverse event patterns, signal awareness, and benefit-risk thinking.
• A workflow where small details can change how a case is assessed or reported.

You may prefer regulatory affairs if you like

• Submission planning, CTD structure, labeling, variations, renewals, and lifecycle management.
• Tracking guidance, country requirements, health authority questions, and product claims.
• Organizing evidence into structured documents and managing changes over time.
• A workflow where communication, timing, and document control are central.

A practical decision rule

If you are drawn to safety cases and clinical meaning, start with pharmacovigilance. If you are drawn to product lifecycle, submissions, and authority-facing work, start with regulatory affairs. If you are unsure, learn the basics of both and compare which tasks feel more natural.